Due to the considerable number of risk factors for overdose in patients with OUD or those on high dose opioids for chronic pain, it is imperative that health care professionals (HCPs) are familiar with the use of naloxone and its availability. Naloxone products for home use by patients or caregivers can reduce the risk of overdose deaths in both patients and household contacts; therefore, it is imperative that HCPs educate patients who are at risk for overdose on its role and means of administration.
The final episode of this CMEOCast podcast series highlights the multitude of risk factors for opioid overdose that clinicians treating patients with chronic pain need to be aware of, as well as strategies for counseling patients about naloxone.
At the end of this CME/CE activity, participants should be able to:
The following learning objectives pertain only to those requesting CNE or CPE credit:
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Physicians, dentists, PAs, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Skolnik has no disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-097-H08-P.
Call us at 877.CME.PROS (877.263.7767).